Clinical Trial

Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an observational, prospective study enrolling patients who meet the inclusion criteria and provide consent for the use of biopsy samples collected as part of standard clinical practice. The analysis will focus on the following biomarkers: TP53, P16, Cyclin D1, EGFR, Akt, PDL-1, and ERCC1. These biomarkers will be examined in both observation groups.
Trial Details
NCT Number NCT06905145
Lead Sponsor National Cancer Institute, Naples
Conditions Head and Neck Squamous Cell Carcinoma, Locally Advanced Stage
Enrollment 128 participants
Start Date 2024-05-03
Primary Completion 2026-05 (estimated)
Study Completion 2032-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-01